Targeting metabolic dysfunction in amyotrophic lateral sclerosis: therapeutic potential of GLP-1 receptor agonists. - Helal MM; Almosilhy NA; Abo-Elnour DE; Jaffal RSY; Allam EG; Almosilhy MA; Batarseh SF; Meshref M (Amyotrophic lateral sclerosis & frontotemporal degeneration, 2026)